Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

5.24
+0.03000.58%
Post-market: 5.240.00000.00%16:05 EDT
Volume:120.11K
Turnover:626.90K
Market Cap:224.07M
PE:-9.47
High:5.34
Open:5.25
Low:5.11
Close:5.21
Loading ...

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m

Simply Wall St.
·
19 Dec 2024

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Diamedica Therapeutics (DMAC)

TIPRANKS
·
16 Dec 2024

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of Dm199 for the Treatment of Preeclampsia

THOMSON REUTERS
·
03 Dec 2024

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia

Business Wire
·
03 Dec 2024

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate

Simply Wall St.
·
16 Nov 2024

Lake Street Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC)

TIPRANKS
·
15 Nov 2024

Q3 2024 DiaMedica Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Nov 2024

DiaMedica Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

DiaMedica Therapeutics Q3 2024 GAAP EPS $(0.15), Inline

Benzinga
·
14 Nov 2024

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics Inc: Cash Runway Into Q3 2026

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics doses first patient in Phase 2 DM199 trial

TIPRANKS
·
14 Nov 2024

DiaMedica Therapeutics Inc - Top Line Data for Part 1a Expected in First Half of 2025

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of Dm199 in the Treatment of Preeclampsia

THOMSON REUTERS
·
14 Nov 2024

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia

Business Wire
·
14 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 Nov 2024